AKT1 and cancer: Bay11-7085 treatment of PEL cells has the ability to down-regulate the expression of anti-apoptotic and pro-survival targets of p65 that play major roles in the prevention of apoptosis and survival of cancer cells; it also has the ability to inactivate the expression of Bad, a down-stream target of AKT [35].